UNASSIGNED: A cross-over design was used in 3 phases for the intramuscular injection of three different products: procaine BP alone, procaine BP/ benzathine BP combination or penethamate hydriodide were administered IM in the gluteal muscles of 6 horses for 3 days. Single IV administration of sodium BP was performed to the same horses with a dose of 22,000 IU BP/kg bwt 39 weeks after last IM injection. BP plasma concentrations were determined by UPLC assay coupled with mass spectrometry and a PK/PD analysis was conducted to predict the efficacy of various dosing regimens by estimating values of the fT>MIC index for different minimum inhibitory concentrations (MIC). Tolerance at the site of IM injection was monitored by creatine kinase activity quantified with a validated chemistry system and clinical scorings.
UNASSIGNED: Except one neurological reaction following one administration of penethamate hydriodide, the tolerance was good. Procaine BP alone, procaine BP/benzathine BP combination or penethamate hydriodide intramuscular administrations at a dosage of 22,000 IU BP/kg bwt q24h for 5 days would yield plasma concentrations that should be effective against bacteria with MIC of ≤0.256, 0.125 or 0.064 mg/L respectively. Of all the tested treatments, the use of a sodium BP by IV Constant Rate Infusion (CRI) for 10 hours a day was deemed to be the most efficient. All the formulations tested in this study are adequate to treat infections with susceptible Streptococcus equi.
■在3个阶段中使用了交叉设计,用于肌内注射三种不同的产品:普鲁卡因BP单药,普鲁卡因BP/苄星BP组合或氢碘化物在6匹马的臀肌中IM给药3天。在最后一次IM注射后39周以22,000IUBP/kgbwt的剂量对相同的马进行BP钠的单次IV施用。通过与质谱联用的UPLC测定确定BP血浆浓度,并进行PK/PD分析以通过估计不同最小抑制浓度(MIC)的fT>MIC指数来预测各种给药方案的功效。通过用经过验证的化学系统和临床评分定量的肌酸激酶活性来监测IM注射部位的耐受性。
■除了一次给予氢碘化物后的一次神经反应,宽容是好的。仅普鲁卡因血压,以22,000IUBP/kgbwtq24h的剂量肌肉内给药普鲁卡因BP/苄星BP组合或氢化苯甲酸盐5天,将产生对MIC≤0.256、0.125或0.064mg/L的细菌有效的血浆浓度。在所有测试的治疗中,通过静脉恒定速率输注(CRI)每天10小时使用钠BP被认为是最有效的。本研究中测试的所有制剂都足以治疗易感的马链球菌感染。